Early data from renal cancer dual drug trial reinforces cancer field’s optimism for immunotherapy approaches.
Dr. W. Michael Park shares insight through his experiences and expertise in the field of vascular surgery.
Certain topics presented at ACC 2014 are likely to have greater impact on patient care than others. Steven Nissen, MD, chairman of Cardiovascular Medicine at Cleveland Clinic, shares his top five choices.
In SYMPLICITY HTN-3, renal denervation produced a mean systolic blood pressure drop of 14 mmHg—only slightly more than the 12 mmHg experienced by patients in the sham treatment arm.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Novel approach to breast cancer treatment may help prevent premature ovarian failure and boost both fertility and survival.
Pancreatic adenocarcinomas benefit from a multidisciplinary treatment approach. At Cleveland Clinic, a new pancreatic cancer clinic can help.
A simple test allows clinicians to identify which heart-failure patients suffer from cognitive impairment and may be more likely to be readmitted or die within 30 days of discharge than patients who ace the test.
The latest radiation therapies for treating breast cancer minimize exposure to the heart and reduce likelihood of survivors developing late cardiac complications.
As improved interventions in oncology have led to better outcomes, cancer survivorship has become an increasingly relevant area of clinical research and treatment. The American Society of Clinical Oncology (ASCO) recently released a new set of clinical practice guidelines focused on survivorship.
Results of a US Pivotal Trial secures TAVR s position as the treatment of choice for patients with severe aortic stenosis who cannot undergo surgery and an attractive alternative to standard surgical aortic valve replacement in operable but high-risk patients.